BIO RAD LABORATORIES INC. – LIQUICHEK TUMOR REGEANTS
| Agency: | HEALTH AND HUMAN SERVICES, DEPARTMENT OF |
|---|---|
| State: | Maryland |
| Type of Government: | Federal |
| FSC Category: |
|
| NAICS Category: |
|
| Set Aside: | No Set aside used |
| Posted Date: | May 14, 2026 |
| Due Date: | May 24, 2026 |
| Solicitation No: | 26-005107 |
| Original Source: | Please Login to View Page |
| Contact information: | Please Login to View Page |
| Bid Documents: | Please Login to View Page |
Description
APEX Accelerators are an official government contracting resource for small businesses. Find your local APEX Accelerator (opens in new window) for free government expertise related to contract opportunities.
APEX Accelerators are funded in part through a cooperative agreement with the Department of Defense.
The APEX Accelerators program was formerly known as the Procurement Technical Assistance Program (opens in new window) (PTAP).
- Contract Opportunity Type: Presolicitation (Original)
- Original Published Date: May 14, 2026 02:57 pm EDT
- Original Response Date: May 24, 2026 02:00 pm EDT
- Inactive Policy: 15 days after response date
- Original Inactive Date: Jun 08, 2026
-
Initiative:
- None
- Original Set Aside: No Set aside used
- Product Service Code: 6515 - MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES
-
NAICS Code:
- 325413 - In-Vitro Diagnostic Substance Manufacturing
-
Place of Performance:
Bethesda , MD 20892USA
Place of Performance:
National Institutes of Health
Clinical Center
Bethesda, MD 20892
POTS: 26-005107
Description
This notice is issued for informational purposes only and does not constitute a request for quotations. A solicitation will not be issued, and quotations will not be requested.
The National Institutes of Health (NIH), Clinical Center, intends to award a sole source firm-fixed-price contract to Bio-Rad Laboratories for the procurement of Liquichek Tumor Regeants.
The requirement consists of testing controls for cardiac, cancer and infectious disease markers for Liquichek Tumor Regeants, which provide consistent, high-quality results for clinical center patients within the Department of Laboratory Medicine (DLM) Immunoassay laboratory.
Background
The Department of Laboratory Medicine (DLM) Immunoassay laboratory currently provides services for 35 protocols across several Institutes, and they all require highly accurate and rapid results. In addition, some research protocols extend over several years, it is very important for laboratory values to remain consistent over time through the same testing methodologies and similar instrumentation.
Rationale:
Bio-Rad Laboratories is the sole manufacturer of Liquichek Tumor Regeants. Substitution is not permissible without revalidation and regulatory approval, which could delay treatment and pose risks to patient care
Authority
This acquisition is being conducted in accordance with:
FAR 13.106-1(b)(1) – Soliciting from a Single Source
Under this authority, the Contracting Officer may solicit from a single source when it is determined that only one source is reasonably available to meet the Government’s requirements.
Acquisitions conducted under FAR Part 13 – Simplified Acquisition Procedures are exempt from the competition requirements of FAR Part 6.
Responses
This is not a request for quotations. However, interested parties may submit a capability statement demonstrating their ability to meet the Government’s requirement.
Responses must include:
- Company name and address
- Technical capability
- Proof of OEM authorization
- Relevant past performance
The Government will evaluate capability statements received in response to this notice. The determination not to compete this requirement is solely within the discretion of the Government.
Submission Instructions
Responses referencing POTS: 26-005107 must be submitted electronically no later than May 24, 2026, at 8:00 AM EST to:
Gregory Noland
Hospital and Laboratory Support Division
Office of Acquisitions and Logistics Management
National Institutes of Health
Email: gregory.noland@nih.gov
- 6011 EXECUTIVE BLVD., SUITE 503L
- BETHESDA , MD 20892
- USA
- Gregory Noland
- gregory.noland@nih.gov
- Phone Number 3018273078
- May 14, 2026 02:57 pm EDTPresolicitation (Original)
See Also
Follow Single cell methylation Active Contract Opportunity Notice ID 75N98026Q01085 Related Notice Department/Ind.
HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Due by 9/20/2026
Follow Specialized Blood Products-AABB Active Contract Opportunity Notice ID 26-008618 Related Notice Department/Ind.
HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Due by 9/20/2026
Follow Electrosurgical unit (ESU) Active Contract Opportunity Notice ID 75F40126Q00277 Related Notice Department/Ind.
HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Due by 9/16/2026
Follow NOTICE OF INTENT TO SOLE SOURCE - PROCUREMENT OF THE BIO-RAD CHEMIDOC
HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Due by 9/18/2026